rinvoq - Blog - Georgette Pierre. I voiced my first TV commercial as the runner in Rinvoq's rafting spot.

USES. RINVOQ is a prescription medicine used to treat: Adults with moderate to severe rheumatoid arthritis (RA) when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated.

by Drugs.com Flavia Watson is the singer on the Humira commercial “Not always where I need to be” released July 16, 2018. She is of South American and Italian origin and is an actor, singer, and songwriter based between Los Angeles and Europe. Flavia was born on April 11, 1991.

He played the Bud Light King in Bud Light's Dilly Dilly television commercials.

Rinvoq has an average rating of 6.3 out of 10 from a total of 130 reviews on Drugs.com. 50% of reviewers reported a positive experience, while 29% reported a negative experience.

Rinvoq (upadacitinib) can raise your risk of serious and sometimes life-threatening infections. The most common serious infections that people have had during treatment include pneumonia and cellulitis (a type of skin infection).

Carolyn Dante is the girl belly dancing in the pink T-shirt who appeared in the Humira commercial, "Body of Proof, Drums" released on January 19th, 2021.

Here are some steps you can take to try to find actors from a commercial:

1. Contact the Company: If the commercial is for a specific product or brand, you can try contacting the company directly.
2. Use Social Media: Many actors and performers have a presence on social media platforms like Twitter, Instagram, and Facebook.

AmericanJohn Hoogenakker / Nationality John Hoogenakker (/ˈhoʊɡənækər/) is an American stage, screen and commercial actor. On stage, he has been in a number of plays in the Chicago and Milwaukee area.

Personal life. Hoogenakker is married and has two children.

No, Rinvoq (upadacitinib) is classified as a Janus kinase (JAK) inhibitor and methotrexate is a disease-modifying antirheumatic drug (DMARD). Both prescription products are approved to treat rheumatoid arthritis in adults.

In patients ≥65 years of age, there is an increased risk of adverse reactions with RINVOQ 30 mg once daily. Consequently, the recommended dose for long-term use in this patient population is 15 mg once daily. Use in combination with other potent immunosuppressants is not recommended.